Protocol Ledger

NCT07759245 · Phase II · RECRUITING

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Interventional Phase II clinical trial protocol NCT07759245 sponsored by Eli Lilly and Company in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-08-07 Enrollment: 606 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07759245
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)606 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07759245
Protocol FieldVerified Registry Value
NCT IdentifierNCT07759245
Consolidated Lead SponsorEli Lilly and Company
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment606 participants (ESTIMATED)
Registered Start Date2026-08-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07759245
Hospital Research SiteLocationSite Profile
University of Alabama at BirminghamBirmingham, ALOpen Hospital Dossier ->
Brigham and Women's HospitalBoston, MAOpen Hospital Dossier ->

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Eli Lilly and Company across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI